# Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus

> **NCT00387309** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 495 (—)

## Conditions studied

- Post Operative Bowel Dysfunction

## Interventions

- **DRUG:** Methylnaltrexone (MOA-728)

## Key facts

- **NCT ID:** NCT00387309
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 495 (—)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387309, "Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00387309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*